Transforming growth factor β receptors and p27(kip) in thyroid carcinoma

Archives of Otolaryngology - Head and Neck Surgery

Volumn 125, Issue 1, 1999, Pages 76-81

  Muro Cacho, Carlos A ^a   Muñoz Antonia, Teresita ^a   Livingston, Sandra ^a   Klotch, Douglas ^a  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D1; PROTEIN P27; TRANSFORMING GROWTH FACTOR BETA RECEPTOR;

ADULT; ARTICLE; CLINICAL ARTICLE; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PROTEIN DETERMINATION; PROTEIN EXPRESSION; THYROID PAPILLARY CARCINOMA;

EID: 0345389976     PISSN: 08864470     EISSN: None     Source Type: Journal    
DOI: 10.1001/archotol.125.1.76     Document Type: Article

References (25)

1. Hartwell LH. Cell cycle control and cancer. Science. 1994;266:1821-1828.
2. Paulovich AG, Toczyski DP, Hartwell LH. When checkpoints fail. Cell. 1997;88: 315-321.
3. Wrana JL, Attisano L. MAD-related proteins in TGF-beta signaling. Trends Genet. 1996;12:493-496
4. Moses HL, Yang EY, Pietenpol JA. TGFβ stimulation and inhibition ot cell proliferation: new mechanistic insights. Cell. 1990;60:245-247.
5. Fynan TM, Reiss M. Resistance to inhibition of cell growth by TGF-β and its role in oncogenesis. Crit Rev Oncog. 1993;4:493-540.
6. Geiser AG, Burmester JK, Webbink R, Roberts AB, Sporn MB. Inhibition of growth by transforming growth factor-β following fusion of two non-responsive human carcinoma cell lines. J Biol Chem. 1992;267:2588-2593.
7. kc, a cyclin-CDK inhibitor, links TGF-β and contact inhibition to cell cycle arrest. Genes Dev. 1994;8:9-22.
8. Muro-Cacho CA, Holt T, Mora L, Livingston S, Klotch D. Cyclin D1 expression as a prognostic marker in papillary carcinoma of the thyroid. Otolaryngol Head Neck Surg. In press.
9. Carcangiu ML, Zampi G, Rupi A, Castagnoli A, Rosai J. Papillary carcinoma of the thyroid: a clinico-pathologic study of 241 cases treated at the University of Florence, Italy. Cancer. 1985;55:805-828.
10. Beahrs OH, Henson DE, Butter RVP, Kennedy BJ. Manual for Staging of Cancerz: American Joint Committee on Cancer. 4th ed. Philadelphia, Pa: JB Lippincott Co; 1992.
11. Baldin V, Lucas J, Marcote MJ, Pagano M, Draetta G. Cyclin D1 is a nuclear protein required lor cell cycle progression in G1. Genes Dev. 1993;7:812-816.
12. Shinozaki H, Ozawa S, Ando N, et al. Cyclin D1 amplification as a new predictive classification for squamous cell carcinoma of the esophagus, adding gene information. Clin Cancer Res. 1996;2:1155-1161.
13. Lazzereschi D, Mincione G, Coppa A, et al. Oncogenes and antioncogenes involved in human thyroid carcinogenesis. Exp Clin Cancer Res. 1997;3:325-332.
14. Weiser R, Attisano L, Wrana JL, Massague J. Signaling activity of TGF-β type II receptors lacking specific domains in the cytoplasm region. Mol Cell Biol. 1993; 13:7239-7247.
15. kp1 in C3H 10 T1/2 mouse fibroblasts. Cancer Res. 1995;55:1413-1416.
16. kp1 display increased body size, multiple organ hyperplasia, retinal dysplasia, and pituitary tumors. Cell. 1996; 85:707-720.
17. Grana X, Reddy EP. Cell cycle control in mammalian cells: role of cyclins, cyclin dependent kinases (CDKs), growth suppressor genes and cyclin-dependent kinase inhibitors (CKls). EMBO. 1995;11:211-219.
18. Bates S, Bonetta L, MacAllan D, et al. cdk6 (PLSTIRE) and cdk4 (PSK-J3) are a distinct subset of the cyclin-dependent kinases that associate with cyclin D1. Oncogene. 1994;9:71-79.
19. Stillman B. Cell cycle control and DNA replication. Science. 1996;274: 1659-1664.
20. Motokura T. Cyclin D and oncogenesis. Curr Biol. 1993;3:5-9.
21. Markovits S, Wang L, Myeroff R, Parsons L, Sun J. Inactivation of the type II TGF-β receptor in colon cancer with microsatellite instability. Science. 1995; 268:1336-1338.
22. Lew DJ, Kornbluth S. Regulatory roles of cyclin-dependent kinase phosphorylation in cell cycle control. Curr Opin Cell Biol. 1996;8:795-804.
23. kp1. Cell. 1996;85: 721-732.
24. Muñoz-Antonia T, Li XC, Jackson R, Reiss M, Antonia SJ. A mutation in the TGF-β type II receptor gene promoter associated with loss of gene expression. Cancer Res. 1996;56:4831-4835,
25. Ohta K, Pang XP, Berg L, Hershman JM. Antitumor actions of cytokines on new human papillary thyroid carcinoma cell lines. J Clin Endocrinol Metab. 1996;81: 2607-2612.